BIOGEN IDEC INC (BIIB) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 1014 transactions totaling $283.6M, demonstrating a bullish sentiment with $82.4M in net insider flow. The most recent transaction on Feb 2, 2026 involved a sale of 748 shares valued at $134.1K.
No significant insider buying has been recorded for BIIB in the recent period.
No significant insider selling has been recorded for BIIB in the recent period.
Based on recent SEC filings, insider sentiment for BIIB is bullish with an Insider Alignment Score of 65/100 and a net flow of $82.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIOGEN IDEC INC (BIIB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading BIIB stock, having executed 1014 transactions in the past 90 days. The most active insider is Alexander J. Denner (Executive), who has made 23 transactions totaling $177.1M.
Get notified when executives and directors at BIIB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Singhal Priya | Head of Development | Sale | 748 | $179.30 | $134.1K | |
| Jan 30, 2026 | Singhal Priya | Head of Development | Option Exercise | 1,829 | $N/A | $0 | |
| Jan 30, 2026 | Singhal Priya | Head of Development | Payment | 582 | $179.89 | $104.7K | |
| Jan 30, 2026 | Singhal Priya | Head of Development | Option Exercise | 1,829 | $N/A | $0 | |
| Dec 1, 2025 | Viehbacher Christopher | Executive | Payment | 3,404 | $177.78 | $605.2K | Large |
| Dec 1, 2025 | Viehbacher Christopher | Executive | Option Exercise | 7,040 | $N/A | $0 | |
| Oct 31, 2025 | Grogan Jane | Executive | Payment | 337 | $154.27 | $52.0K | |
| Oct 31, 2025 | Grogan Jane | Executive | Option Exercise | 695 | $N/A | $0 | |
| Oct 2, 2025 | Godbout Sean | Executive | Payment | 8 | $155.25 | $1.2K | |
| Oct 2, 2025 | Godbout Sean | Executive | Option Exercise | 26 | $N/A | $0 | |
| Sep 2, 2025 | Singhal Priya | Executive | Sale | 517 | $133.55 | $69.0K | |
| Aug 29, 2025 | Singhal Priya | Executive | Option Exercise | 1,669 | $N/A | $0 | |
| Aug 29, 2025 | Singhal Priya | Executive | Payment | 807 | $132.22 | $106.7K | |
| Jul 8, 2025 | Izzar Rachid | Executive | Sale | 2,223 | $135.00 | $300.1K | |
| Sep 3, 2024 | Singhal Priya | Executive | Sale | 431 | $204.22 | $88.0K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 22 | $183.0M | 48.5% |
Sale(S) | 151 | $100.6M | 26.6% |
Payment(F) | 350 | $84.0M | 22.2% |
Exercise(M) | 327 | $9.7M | 2.6% |
Award(A) | 140 | $295.4K | 0.1% |
Gift(G) | 24 | $0 | 0.0% |
Insiders at BIOGEN IDEC INC are accumulating shares at an accelerated pace. With 46 insiders making 1014 transactions totaling $183.0M in purchases versus $100.6M in sales, the net buying activity of $82.4M signals strong executive confidence. Alexander J. Denner (Executive) leads the buying activity with $177.1M in transactions across all time.